Clindepharm (Pty) Ltd is founded as the first CRO in South-Africa by Oppel Greeff and Gillian Corken. Based on their success and track record they were acquired by the leading global CRO in 1998. Oppel and Gillian then played a pivotal role in pioneering the CRO industry across Africa, Asia and Latin America.
Triclinium Clinical Trial Project Management (Pty) Ltd is founded by Victor Strugo as a niche African CRO focused primarily on Regulatory and Monitoring services in clinical trials.
An independent health economics research unit is created within The Risk Monitor Group under the leadership of Tienie Stander. Known as heX (Health Econometrix).
Broadening their services to encompass the increasingly important sphere of outcomes research, heX evolves into heXor (Pty) Ltd.
CyteSpace Research (Pvt) Ltd is founded in India by Ferzaan Engineer - a technology-focused site solutions organisation.
CyteSpace Africa (Pty) Ltd is established under the leadership of Gillian Corken to expand the global footprint and diversified service offerings.
Triclinium adds medical advisory and biometric services, enabling an in-house full-service offering for the first time.
PharmaLTx is established as a software development house focusing on eClinical Solutions.
AcquiPharma Holdings acquires Triclinium.
Triclinium rebranded as Triclinium Clinical Development (TCD).
CyteSpace Africa & heXor merge, forming a Late Phase and Outcomes Research organisation.